Axsome Therapeutics, Inc.AXSMNASDAQ
LOADING
|||
PB Ratio: Premium Valuation
Trending higher, above historical average, strong compound growth.
Left:
||||
Price-to-book ratio
Latest
71.10
↑ 102% above average
Average (9y)
35.27
Historical baseline
Range
High:90.93
Low:2.38
CAGR
+45.8%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | 71.10 | +275.6% |
| 2023 | 18.93 | -33.9% |
| 2022 | 28.62 | -68.5% |
| 2021 | 90.93 | +241.3% |
| 2020 | 26.64 | +35.4% |
| 2019 | 19.67 | -75.7% |
| 2018 | 80.83 | +960.0% |
| 2017 | 7.63 | +27.3% |
| 2016 | 5.99 | +151.3% |
| 2015 | 2.38 | - |